SoylentNews

takyon writes:

The BBC reports that three-person IVF will soon be legal in the United Kingdom. The procedure involves replacing mitochondrial DNA in an embryo from that of a second woman in order to eliminate deadly mitochondrial genetic disorders. Alana Saarinen was successfully conceived in the U.S. using the procedure back in 2000, but the FDA banned ooplasm transfer in 2001.

The UK has now become the first country to approve laws to allow the creation of babies from three people. The modified version of IVF has passed its final legislative obstacle after being approved by the House of Lords. The fertility regulator will now decide how to license the procedure to prevent babies inheriting deadly genetic diseases. The first baby could be born as early as 2016. A large majority of MPs in the House of Commons approved "three-person babies" earlier this month. The House of Lords tonight rejected an attempt to block the plan by a majority of 232. Estimates suggest 150 couples would be suitable to have babies through the technique each year.

Additional coverage at Wired UK and The Guardian.

Related: UK Parliament Gives Three-"Source" IVF the Go-Ahead.

takyon writes:

A National Academy of Medicine (formerly known as the Institute of Medicine) committee has given conditional backing to the use of mitochondrial replacement techniques (MRT). Three-person in vitro fertilisation was approved and legalized in the United Kingdom last year, but has been banned by the U.S. Food and Drug Administration since 2001, despite having been used to conceive a patient back in 2000. Mitochondrial replacement is intended to allow a couple to conceive a child, but with healthy mitochondria inserted into the embryo from a female donor:

Would it be ethical for scientists to try to create babies that have genetic material from three different people? An influential panel of experts has concluded the answer could be yes. The 12-member panel, assembled by the National Academies of Sciences, Engineering and Medicine, released a 164-page report Wednesday outlining a plan for how scientists could ethically pursue the controversial research. "The committee concludes that it is ethically permissible" to conduct such experiments, the report says, but then goes on to detail a long list of conditions that would have to be met first.

For example, scientists would have to perform extensive preliminary research in the laboratory and with animals to try make sure it is safe. And then researchers should initially try to make only male babies, because they would be incapable of passing their unusual amalgamation of DNA on to future generations. "Minimizing risk to future children should be of highest priority," the committee writes.

The report was requested by the Food and Drug Administration in response to applications by two groups of scientists in New York and Oregon to conduct the experiments. Their goal is to help women have healthy babies even though they come from families plagued by [mitochondrial] genetic disorders.

The PDF of the report, "Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations" (DOI: 10.17226/21871) is 8.1 MB and can be downloaded "as guest" with no email confirmation.

Original Submission

takyon writes:

Scientists have recreated heteroplasmy by producing embryos with both maternal and paternal mitochondrial DNA:

A new study published in the Proceedings of the National Academy of Sciences (PNAS) from the University of Missouri has succeeded in creating embryos with "heteroplasmy," or the presence of both maternal and paternal mitochondrial DNA. This new innovation will allow scientists to study treatments for mitochondrial diseases in humans as well as the significance of mitochondrial inheritance for livestock.

When parents pass along their genes to their children, most of the DNA from the mother and father is evenly divided. However, children only receive one type of [mitochondrial DNA] from their mothers, while the fathers' mitochondrial DNA is naturally removed from the embryos. Peter Sutovsky, a professor of reproductive physiology at Mizzou and lead author Won-Hee Song, a doctoral candidate in the Mizzou College of Agriculture, Food and Natural Resources, have found a way to prevent this paternal mitochondrial DNA removal process in pig embryos, thus creating embryos with "heteroplasmy."

"As many as 4,000 children are born in the U.S. every year with some form of mitochondrial disease, which can include poor growth, loss of muscle coordination, learning disabilities and heart disease," Sutovsky said. "Some scientists believe some of these diseases may be caused by heteroplasmy, or cells possessing both maternal and paternal mitochondrial DNA. We have succeeded in creating this condition of heteroplasmy within pig embryos, which will allow scientists to further study whether paternal heteroplasmy could cause mitochondrial diseases in humans."

Autophagy and ubiquitin–proteasome system contribute to sperm mitophagy after mammalian fertilization (DOI: 10.1073/pnas.1605844113) (DX)

Previous/Related:
Project to Repair Mitochondria Funded
Three-Person Babies Could Be Possible in Two Years
U.S. Panel Gives Tentative Endorsement to Three-Person IVF
Newcastle University Study Verifies Safety of Three-Person IVF

Original Submission

takyon writes:

Singapore could become the second country to legalize mitochondrial replacement therapy

This small city state could become the second country—after the United Kingdom—to explicitly legalize mitochondrial replacement therapy (MRT), a controversial assisted reproduction technique that allows women who are carriers of some rare genetic disorders to give birth to healthy babies.

Members of the Singaporean public and religious groups have until 15 June to provide their feedback about MRT to the Bioethics Advisory Committee (BAC). Based on its findings, a 13-member BAC review committee will make formal recommendations to the government later this year about whether to legalize the technology.

"Our position is to keep a close watch on what happens in the U.K., to track the U.K. experience, and to learn from what they have done," says Oi Lian Kon, who studies human genetics at the National Cancer Centre Singapore and is leading the BAC review group.

MRT is used to address devastating genetic diseases that arise from abnormalities in the DNA in mitochondria, the cell's power sources, and that commonly affect energy-intensive organs such as the brain and heart, as well as muscles. Children inherit mitochondria only from their mothers; replacing faulty mitochondria in an egg or embryo with normal ones from a donor can result in healthy babies. But it also means that offspring will bear DNA from three "parents," which makes MRT a controversial procedure.

Previously: UK Parliament Gives Three-"Source" IVF the Go-Ahead.
Approval for Three-Parent Embryo Trials
UK's Fertility Regulator Approves Creation of First "Three-Parent" Babies

Related: U.S. Panel Gives Tentative Endorsement to Three-Person IVF
Newcastle University Study Verifies Safety of Three-Person IVF
First Three-Person Baby Born Using Spindle Nuclear Transfer
Baby Girl Born in Ukraine Using Three-Parent Pronuclear Transfer Technique

Original Submission

upstart writes:

Mitochondrial donation treatment aims to prevent children from inheriting incurable diseases:

The first UK baby created with DNA from three people has been born after doctors performed a groundbreaking IVF procedure that aims to prevent children from inheriting incurable diseases.

The technique, known as mitochondrial donation treatment (MDT), uses tissue from the eggs of healthy female donors to create IVF embryos that are free from harmful mutations their mothers carry and are likely to pass on to their children.

Because the embryos combine sperm and egg from the biological parents with tiny battery-like structures called mitochondria from the donor's egg, the resulting baby has DNA from the mother and father as usual, plus a small amount of genetic material – about 37 genes – from the donor.

The process has led to the phrase "three-parent babies", though more than 99.8% of the DNA in the babies comes from the mother and father.

Research on MDT, which is also known as mitochondrial replacement therapy (MRT), was pioneered in the UK by doctors at the Newcastle Fertility Centre. The work aimed to help women with mutated mitochondria to have babies without the risk of passing on genetic disorders. People inherit all their mitochondria from their mother, so harmful mutations in the "batteries" can affect all of the children a woman has.

[...] The Newcastle process has several steps. First, sperm from the father is used to fertilise eggs from the affected mother and a healthy female donor. The nuclear genetic material from the donor's egg is then removed and replaced with that from the couple's fertilised egg. The resulting egg has a full set of chromosomes from both parents, but carries the donor's healthy mitochondria instead of the mother's faulty ones. This is then implanted in the womb.